688566 吉贝尔
交易中 04-28 11:22:57
资讯
新帖
简况
4月23日吉贝尔跌6.29%，国泰聚信价值优势混合A基金重仓该股
证券之星 · 04-23
4月23日吉贝尔跌6.29%，国泰聚信价值优势混合A基金重仓该股
吉贝尔(688566.SH)向93名激励对象授予160万股限制性股票
智通财经 · 04-10
吉贝尔(688566.SH)向93名激励对象授予160万股限制性股票
3月23日吉贝尔跌5.27%，国泰聚信价值优势混合A基金重仓该股
证券之星 · 03-23
3月23日吉贝尔跌5.27%，国泰聚信价值优势混合A基金重仓该股
每周股票复盘：吉贝尔（688566）因融资买入量占比超50%登龙虎榜
证券之星 · 03-22
每周股票复盘：吉贝尔（688566）因融资买入量占比超50%登龙虎榜
3月19日吉贝尔（688566）龙虎榜数据
证券之星 · 03-19
3月19日吉贝尔（688566）龙虎榜数据
吉贝尔(688566)2月13日股东户数0.82万户，较上期增加3.38%
证券之星 · 02-25
吉贝尔(688566)2月13日股东户数0.82万户，较上期增加3.38%
每周股票复盘：吉贝尔（688566）股东户数增6.59%，户均持股降
证券之星 · 01-25
每周股票复盘：吉贝尔（688566）股东户数增6.59%，户均持股降
每周股票复盘：吉贝尔（688566）股东户数增3.35%至7406户
证券之星 · 01-18
每周股票复盘：吉贝尔（688566）股东户数增3.35%至7406户
吉贝尔(688566)1月9日股东户数0.74万户，较上期增加3.35%
证券之星 · 01-13
吉贝尔(688566)1月9日股东户数0.74万户，较上期增加3.35%
每周股票复盘：吉贝尔（688566）部分募投项目结项并补流
证券之星 · 01-02
每周股票复盘：吉贝尔（688566）部分募投项目结项并补流
吉贝尔（688566）披露部分首发募投项目结项并将节余募集资金永久补流、部分项目调整实施进度，12月29日股价下跌0.17%
证券之星 · 2025-12-29
吉贝尔（688566）披露部分首发募投项目结项并将节余募集资金永久补流、部分项目调整实施进度，12月29日股价下跌0.17%
吉贝尔(688566)11月28日股东户数0.71万户，较上期减少8.45%
证券之星 · 2025-12-02
吉贝尔(688566)11月28日股东户数0.71万户，较上期减少8.45%
吉贝尔：11月6日接受机构调研，包括知名机构正圆投资的多家机构参与
证券之星 · 2025-11-10
吉贝尔：11月6日接受机构调研，包括知名机构正圆投资的多家机构参与
每周股票复盘：吉贝尔（688566）尼群洛尔前三季度增47.09%
证券之星 · 2025-11-09
每周股票复盘：吉贝尔（688566）尼群洛尔前三季度增47.09%
股市必读：吉贝尔（688566）11月4日披露最新机构调研信息
证券之星 · 2025-11-05
股市必读：吉贝尔（688566）11月4日披露最新机构调研信息
每周股票复盘：吉贝尔（688566）股东户数增28.97%，Q3净利降9.45%
证券之星 · 2025-11-02
每周股票复盘：吉贝尔（688566）股东户数增28.97%，Q3净利降9.45%
吉贝尔（688566）2025年三季报简析：营收净利润同比双双增长，盈利能力上升
证券之星 · 2025-11-01
吉贝尔（688566）2025年三季报简析：营收净利润同比双双增长，盈利能力上升
图解吉贝尔三季报：第三季度单季净利润同比下降9.45%
证券之星 · 2025-10-30
图解吉贝尔三季报：第三季度单季净利润同比下降9.45%
吉贝尔：公司会综合考虑技术成熟度、业务需求、成本效益等多方面因素，审慎评估
互动易 · 2025-03-10
吉贝尔：公司会综合考虑技术成熟度、业务需求、成本效益等多方面因素，审慎评估
吉贝尔：关于DeepSeek的部署会综合考虑多方面因素审慎评估
证券之星 · 2025-03-10
吉贝尔：关于DeepSeek的部署会综合考虑多方面因素审慎评估
加载更多
公司概况
公司名称：
江苏吉贝尔药业股份有限公司
所属行业：
医药制造业
上市日期：
2020-05-18
主营业务：
江苏吉贝尔药业股份有限公司的主营业务是药物研发、生产、销售。公司的主要产品是利可君片、尼群洛尔片、玉屏风胶囊、醋氯芬酸肠溶片。公司是国家级专精特新“小巨人”企业。
发行价格：
23.69
{"stockData":{"symbol":"688566","market":"SH","secType":"STK","nameCN":"吉贝尔","latestPrice":28.15,"timestamp":1777346577000,"preClose":28.77,"halted":0,"volume":1602156,"delay":0,"changeRate":-0.0216,"floatShares":199000000,"shares":199000000,"eps":1.2118,"marketStatus":"交易中","change":-0.62,"latestTime":"04-28 11:22:57","open":28.51,"high":28.94,"low":28.08,"amount":45753200,"amplitude":0.0299,"askPrice":28.15,"askSize":7,"bidPrice":28.14,"bidSize":42,"shortable":0,"etf":0,"ttmEps":1.2118,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1777347000000},"marketStatusCode":2,"adr":0,"adjPreClose":28.77,"symbolType":"stock_kcb","openAndCloseTimeList":[[1777339800000,1777347000000],[1777352400000,1777359600000]],"highLimit":31.65,"lowLimit":25.89,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":199430865,"isCdr":false,"pbRate":2.43,"roa":"--","peRate":23.229906,"roe":"1.71%","epsLYR":1.13,"committee":0.65616,"marketValue":5614000000,"turnoverRate":0.008,"status":1,"floatMarketCap":5614000000},"requestUrl":"/m/hq/s/688566","defaultTab":"news","newsList":[{"id":"2629886524","title":"4月23日吉贝尔跌6.29%，国泰聚信价值优势混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2629886524","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629886524?lang=zh_cn&edition=full","pubTime":"2026-04-23 16:28","pubTimestamp":1776932931,"startTime":"0","endTime":"0","summary":"证券之星消息，4月23日吉贝尔跌6.29%，收盘报29.52元，换手率2.53%，成交量5.04万手，成交额1.51亿元。重仓吉贝尔的公募基金请见下表：根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共9家，其中持有数量最多的公募基金为国泰基金的国泰聚信价值优势混合A。国泰聚信价值优势混合A目前规模为12.55亿元，最新净值3.021，较上一交易日上涨0.13%，近一年上涨62.29%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042300044836.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688566","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626197451","title":"吉贝尔(688566.SH)向93名激励对象授予160万股限制性股票","url":"https://stock-news.laohu8.com/highlight/detail?id=2626197451","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626197451?lang=zh_cn&edition=full","pubTime":"2026-04-10 20:15","pubTimestamp":1775823332,"startTime":"0","endTime":"0","summary":"智通财经APP讯，吉贝尔(688566.SH)发布公告，公司于2026年4月10日召开第四届董事会第二十次会议，审议通过了《关于调整公司2025年限制性股票激励计划限制性股票授予价格的议案》《关于向公司2025年限制性股票激励计划激励对象授予预留限制性股票的议案》，同意本激励计划预留限制性股票授予日为2026年4月10日，并同意以11.62元/股的授予价格向93名激励对象授予160万股限制性股票。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1427273.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","688566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621766697","title":"3月23日吉贝尔跌5.27%，国泰聚信价值优势混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2621766697","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621766697?lang=zh_cn&edition=full","pubTime":"2026-03-23 16:41","pubTimestamp":1774255307,"startTime":"0","endTime":"0","summary":"证券之星消息，3月23日吉贝尔跌5.27%，收盘报28.06元，换手率1.59%，成交量3.16万手，成交额9041.5万元。重仓吉贝尔的公募基金请见下表：根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共9家，其中持有数量最多的公募基金为国泰基金的国泰聚信价值优势混合A。国泰聚信价值优势混合A目前规模为13.34亿元，最新净值2.821，较上一交易日下跌1.29%，近一年上涨34.91%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300025429.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621799511","title":"每周股票复盘：吉贝尔（688566）因融资买入量占比超50%登龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2621799511","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621799511?lang=zh_cn&edition=full","pubTime":"2026-03-22 02:47","pubTimestamp":1774118827,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘，吉贝尔报收于29.62元，较上周的29.95元下跌1.1%。本周，吉贝尔3月16日盘中最高价报30.7元。3月20日盘中最低价报29.48元。吉贝尔当前最新总市值59.07亿元，在化学制药板块市值排名86/150，在两市A股市值排名2973/5190。交易信息汇总沪深交易所2026年3月19日公布的交易公开信息显示，吉贝尔因单只标的证券的当日融资买入数量达到当日该证券总交易量的50%以上登上龙虎榜。此次是近5个交易日内第1次上榜。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032200000713.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620124667","title":"3月19日吉贝尔（688566）龙虎榜数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2620124667","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620124667?lang=zh_cn&edition=full","pubTime":"2026-03-19 17:52","pubTimestamp":1773913943,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年3月19日公布的交易公开信息显示，吉贝尔因单只标的证券的当日融资买入数量达到当日该证券总交易量的50%以上登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年3月19日收盘，吉贝尔报收于29.83元，下跌1.58%，换手率1.55%，成交量3.09万手，成交额9233.15万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031900030866.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614702587","title":"吉贝尔(688566)2月13日股东户数0.82万户，较上期增加3.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614702587","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614702587?lang=zh_cn&edition=full","pubTime":"2026-02-25 17:16","pubTimestamp":1772011004,"startTime":"0","endTime":"0","summary":"证券之星消息，近日吉贝尔披露，截至2026年2月13日公司股东户数为8195.0户，较2月10日增加268.0户，增幅为3.38%。在化学制药行业个股中，吉贝尔股东户数低于行业平均水平，截至2月13日，化学制药行业平均股东户数为3.43万户。从股价来看，2026年2月10日至2026年2月13日，吉贝尔区间涨幅为1.53%，在此期间股东户数增加268.0户，增幅为3.38%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022500027515.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606960232","title":"每周股票复盘：吉贝尔（688566）股东户数增6.59%，户均持股降","url":"https://stock-news.laohu8.com/highlight/detail?id=2606960232","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606960232?lang=zh_cn&edition=full","pubTime":"2026-01-25 02:39","pubTimestamp":1769279948,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘，吉贝尔报收于29.91元，较上周的29.5元上涨1.39%。本周，吉贝尔1月19日盘中最高价报30.87元。本周关注点股本股东变化：股东户数较上期增加6.59%，达7894.0户股本股东变化：户均持股数量由2.69万股降至2.53万股股本股东变化股东户数变动截至2026年1月20日，公司股东户数为7894.0户，较1月9日增加488.0户，增幅6.59%。户均持股数量由上期的2.69万股减少至2.53万股，户均持股市值为75.64万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012500000820.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604251059","title":"每周股票复盘：吉贝尔（688566）股东户数增3.35%至7406户","url":"https://stock-news.laohu8.com/highlight/detail?id=2604251059","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604251059?lang=zh_cn&edition=full","pubTime":"2026-01-18 04:17","pubTimestamp":1768681026,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘，吉贝尔报收于29.5元，较上周的30.91元下跌4.56%。本周，吉贝尔1月13日盘中最高价报31.08元。1月16日盘中最低价报29.15元。吉贝尔当前最新总市值58.83亿元，在化学制药板块市值排名88/150，在两市A股市值排名3108/5183。股本股东变化股东户数变动截至2026年1月9日，公司股东户数为7406.0户，较12月19日增加240.0户，增幅3.35%。户均持股数量由上期的2.78万股下降至2.69万股，户均持股市值为83.24万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011800001287.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603023625","title":"吉贝尔(688566)1月9日股东户数0.74万户，较上期增加3.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603023625","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603023625?lang=zh_cn&edition=full","pubTime":"2026-01-13 17:34","pubTimestamp":1768296878,"startTime":"0","endTime":"0","summary":"证券之星消息，近日吉贝尔披露，截至2026年1月9日公司股东户数为7406.0户，较12月19日增加240.0户，增幅为3.35%。在化学制药行业个股中，吉贝尔股东户数低于行业平均水平，截至1月9日，化学制药行业平均股东户数为3.44万户。从股价来看，2025年12月19日至2026年1月9日，吉贝尔区间涨幅为6.29%，在此期间股东户数增加240.0户，增幅为3.35%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011300029531.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688566","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2600036247","title":"每周股票复盘：吉贝尔（688566）部分募投项目结项并补流","url":"https://stock-news.laohu8.com/highlight/detail?id=2600036247","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600036247?lang=zh_cn&edition=full","pubTime":"2026-01-02 03:25","pubTimestamp":1767295513,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，吉贝尔报收于29.62元，较上周的29.08元上涨1.86%。本周，吉贝尔12月25日盘中最高价报29.98元。本周关注点公司公告汇总：吉贝尔部分首发募投项目结项，节余募集资金2,849.87万元永久补充流动资金。国金证券核查意见：江苏吉贝尔药业股份有限公司部分首发募投项目结项，研发中心（新址）建设项目实际使用募集资金5,880.22万元，节余资金2,849.87万元拟永久补充流动资金。相关事项已通过董事会审议，保荐机构无异议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010200000900.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688566","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2595867777","title":"吉贝尔（688566）披露部分首发募投项目结项并将节余募集资金永久补流、部分项目调整实施进度，12月29日股价下跌0.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595867777","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595867777?lang=zh_cn&edition=full","pubTime":"2025-12-29 17:46","pubTimestamp":1767001579,"startTime":"0","endTime":"0","summary":"截至2025年12月29日收盘，吉贝尔报收于29.57元，较前一交易日下跌0.17%，最新总市值为58.97亿元。该股当日开盘29.51元，最高29.65元，最低29.15元，成交额达3249.16万元，换手率为0.56%。近日，江苏吉贝尔药业股份有限公司发布公告称，公司对首次公开发行股票募投项目进行调整。其中，研发中心（新址）建设项目已实施完毕并结项，节余募集资金2,849.87万元将永久补充流动资金。上述事项已经公司董事会审议通过，保荐机构对此无异议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122900024495.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2588803931","title":"吉贝尔(688566)11月28日股东户数0.71万户，较上期减少8.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588803931","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588803931?lang=zh_cn&edition=full","pubTime":"2025-12-02 17:41","pubTimestamp":1764668515,"startTime":"0","endTime":"0","summary":"证券之星消息，近日吉贝尔披露，截至2025年11月28日公司股东户数为7107.0户，较10月31日减少656.0户，减幅为8.45%。在化学制药行业个股中，吉贝尔股东户数低于行业平均水平，截至11月28日，化学制药行业平均股东户数为3.45万户。从股价来看，2025年10月31日至2025年11月28日，吉贝尔区间跌幅为16.45%，在此期间股东户数减少656.0户，减幅为8.45%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120200026323.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688566","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2582817021","title":"吉贝尔：11月6日接受机构调研，包括知名机构正圆投资的多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2582817021","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582817021?lang=zh_cn&edition=full","pubTime":"2025-11-10 10:03","pubTimestamp":1762740239,"startTime":"0","endTime":"0","summary":"JJH201501疗效确切、不良反应明确且程度较轻、药物相互作用少，成功上市后有望成为抗抑郁一线用药。临床试验结果显示，JJH201501大部分常见不良反应发生率，10 mg组低于氢溴酸伏硫西汀片20mg组，15mg组低于或与氢溴酸伏硫西汀片20 mg组相当；导致受试者脱落和永久停药的不良反应发生率，10 mg组和15 mg组与安慰剂组相当，均低于氢溴酸伏硫西汀片20 mg组，表现出良好的安全性和耐受性。预计JJH201501用药周期与伏硫西汀类似。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111000004673.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2582861125","title":"每周股票复盘：吉贝尔（688566）尼群洛尔前三季度增47.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582861125","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582861125?lang=zh_cn&edition=full","pubTime":"2025-11-09 04:05","pubTimestamp":1762632318,"startTime":"0","endTime":"0","summary":"截至2025年11月7日收盘，吉贝尔报收于31.65元，较上周的35.2元下跌10.09%。本周，吉贝尔11月3日盘中最高价报35.3元。本周关注点来自机构调研要点：尼群洛尔片2025年前三季度实现销售收入13,528.65万元，同比增长47.09%。其中利可君片收入48,545.78万元，同比增长4.17%；尼群洛尔片收入13,528.65万元，同比增长47.09%；其他产品合计8,368.80万元，同比基本持平。答：2025年前三季度研发投入5,232.76万元，费用化3,021.22万元，资本化2,211.54万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110900001485.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688566","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581768942","title":"股市必读：吉贝尔（688566）11月4日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2581768942","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581768942?lang=zh_cn&edition=full","pubTime":"2025-11-05 02:55","pubTimestamp":1762282512,"startTime":"0","endTime":"0","summary":"截至2025年11月4日收盘，吉贝尔报收于32.8元，下跌3.93%，换手率2.17%，成交量4.33万手，成交额1.42亿元。2025年前三季度公司总营收7.04亿元，同比增长9.52%；其中利可君片收入4.85亿元，同比增长4.17%；尼群洛尔片收入1.35亿元，同比增长47.09%；其他产品收入8368.80万元，同比基本持平。2025年前三季度研发投入5232.76万元，其中费用化3021.22万元，主要用于JJH201601等在研项目；资本化2211.54万元，主要用于JJH201501。预计明年费用化研发支出将随JJH201601推进而增加，但因JJH201501完成临床，总体投入增幅有限。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110500001395.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2580473002","title":"每周股票复盘：吉贝尔（688566）股东户数增28.97%，Q3净利降9.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580473002","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580473002?lang=zh_cn&edition=full","pubTime":"2025-11-02 02:38","pubTimestamp":1762022292,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘，吉贝尔报收于35.2元，较上周的31.88元上涨10.41%。业绩披露要点财务报告吉贝尔2025年三季报显示，前三季度主营收入7.04亿元，同比上升9.52%；归母净利润1.97亿元，同比上升12.8%；扣非净利润1.53亿元，同比下降9.85%。公司公告汇总吉贝尔2025年第三季度报告2025年前三季度营业收入704,432,339.33元，同比增长9.52%；归母净利润196,904,169.03元，同比增长12.80%；扣非净利润153,453,563.00元，同比下降9.85%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110200000425.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2580417654","title":"吉贝尔（688566）2025年三季报简析：营收净利润同比双双增长，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2580417654","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580417654?lang=zh_cn&edition=full","pubTime":"2025-11-01 06:52","pubTimestamp":1761951166,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期吉贝尔发布2025年三季报。截至本报告期末，公司营业总收入7.04亿元，同比上升9.52%，归母净利润1.97亿元，同比上升12.8%。本报告期吉贝尔盈利能力上升，毛利率同比增幅0.2%，净利率同比增幅2.6%。答：2025年半年度，公司总体经营平稳向好，实现营业收入45,491.51万元，同比增长4.90%，归属于上市公司股东的净利润14,931.57万元，同比增长22.38%；截至报告期末，公司总资产264,969.28万元，同比增长4.83%，归属于上市公司股东的净资产235,287.07万元，同比增长4.64%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110100008025.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2579439901","title":"图解吉贝尔三季报：第三季度单季净利润同比下降9.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579439901","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579439901?lang=zh_cn&edition=full","pubTime":"2025-10-30 19:37","pubTimestamp":1761824262,"startTime":"0","endTime":"0","summary":"证券之星消息，吉贝尔2025年三季报显示，前三季度公司主营收入7.04亿元，同比上升9.52%；归母净利润1.97亿元，同比上升12.8%；扣非净利润1.53亿元，同比下降9.85%；其中2025年第三季度，公司单季度主营收入2.5亿元，同比上升19.08%；单季度归母净利润4758.85万元，同比下降9.45%；单季度扣非净利润4681.05万元，同比下降7.98%；负债率10.22%，投资收益-226.39万元，财务费用-383.78万元，毛利率89.69%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000040204.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518225343","title":"吉贝尔：公司会综合考虑技术成熟度、业务需求、成本效益等多方面因素，审慎评估","url":"https://stock-news.laohu8.com/highlight/detail?id=2518225343","media":"互动易","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518225343?lang=zh_cn&edition=full","pubTime":"2025-03-10 18:06","pubTimestamp":1741601166,"startTime":"0","endTime":"0","summary":"有投资者向吉贝尔提问， 董秘您好！请问贵公司是否已经部署了DeepSeek？如果已经部署了，请问主要应用于哪些具体的业务？公司接入DeepSeek有哪些成本、收益方面的考量？如果公司计划在未来再进行部署，计划将DeepSeek应用于什么具体的业务呢？我们投资者非常期待您的回复，谢谢！公司回答表示，尊敬的投资者，您好！ 公司始终致力于通过技术创新推动业务发展，提升公司的核心竞争力和股东价值。关于DeepSeek的部署及相关应用，公司会综合考虑技术成熟度、业务需求、成本效益等多方面因素，审慎评估。 感谢您的关注！","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310181552a269d8e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310181552a269d8e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688566","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518243009","title":"吉贝尔：关于DeepSeek的部署会综合考虑多方面因素审慎评估","url":"https://stock-news.laohu8.com/highlight/detail?id=2518243009","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518243009?lang=zh_cn&edition=full","pubTime":"2025-03-10 18:03","pubTimestamp":1741600995,"startTime":"0","endTime":"0","summary":"证券之星消息，吉贝尔03月10日在投资者关系平台上答复投资者关心的问题。请问贵公司是否已经部署了DeepSeek？公司接入DeepSeek有哪些成本、收益方面的考量？如果公司计划在未来再进行部署，计划将DeepSeek应用于什么具体的业务呢？公司始终致力于通过技术创新推动业务发展，提升公司的核心竞争力和股东价值。关于DeepSeek的部署及相关应用，公司会综合考虑技术成熟度、业务需求、成本效益等多方面因素，审慎评估。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025031000026254.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688566"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1777346581224,"stockEarnings":[{"period":"1week","weight":-0.0725},{"period":"1month","weight":-0.031},{"period":"3month","weight":-0.0181},{"period":"6month","weight":-0.1384},{"period":"1year","weight":0.2118},{"period":"ytd","weight":-0.0362}],"compareEarnings":[{"period":"1week","weight":0.001},{"period":"1month","weight":0.0441},{"period":"3month","weight":-0.0129},{"period":"6month","weight":0.0174},{"period":"1year","weight":0.2401},{"period":"ytd","weight":0.0296}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"江苏吉贝尔药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"9109人(较上一季度增加7.03%)","perCapita":"21893股","listingDate":"2020-05-18","address":"江苏省镇江市润州区高新技术产业开发园区","registeredCapital":"19943万元","survey":" 江苏吉贝尔药业股份有限公司的主营业务是药物研发、生产、销售。公司的主要产品是利可君片、尼群洛尔片、玉屏风胶囊、醋氯芬酸肠溶片。公司是国家级专精特新“小巨人”企业。","listedPrice":23.69},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"吉贝尔(688566)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供吉贝尔(688566)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"吉贝尔,688566,吉贝尔股票,吉贝尔股票老虎,吉贝尔股票老虎国际,吉贝尔行情,吉贝尔股票行情,吉贝尔股价,吉贝尔股市,吉贝尔股票价格,吉贝尔股票交易,吉贝尔股票购买,吉贝尔股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"吉贝尔(688566)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供吉贝尔(688566)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}